New Drug Trial/Release Sample

3 June 2016

First Hormone-Free Male Pill Soon To Be A Reality


Brisbane, Queensland — A hormone-free male pill may soon become a reality, with University of Gadget scientists moving closer to developing a new combination of oral contraceptive drugs that together block the transport of sperm during ejaculation.

A hormone-free pill would have the unique ability to bypass the side-effects that have up until now hindered development of a male contraceptive. Such side-effects are often caused from interfering with male hormones including long-term irreversible effects on fertility, birth defects in future offspring and libido.

The team of scientists have previously shown that male infertility could be genetically achieved by simultaneously deleting two proteins that trigger the transport of sperm but without affecting the long-term viability of sperm or sexual and general health. The sperm is effectively there but the muscle is just not receiving the chemical message to move it.

There is already a widely-available drug approved for long-term use that targets one of the two proteins successfully, but the researchers are now looking to develop an oral contraceptive drug to block the second protein.

New funding from the Male Contraceptive Initiative has allowed researchers from the University of Gadget Pharmaceutical Sciences (UGPS) to move into this next phase of drug development but the team is still relying on a large amount of funding to fast-track the process.

Other UGPS researchers involved in the project include Professors Jac Bell, Hugh Johnson and Shannon Raj.


The University of Gadget is an institution committed to academic excellence with specialty in medicine spanning over 50 years. The institution prides itself on its numerous significant discoveries throughout its existence.

Contact information:

Jo Sample
[email protected]
0400 000 000